About Akili
Akili Interactive is pioneering a new class of digital medicines that combine world-class neuroscience with video game technology to treat cognitive impairments. The company has developed proprietary technology platforms that deliver specific sensory stimuli and motor challenges designed to target neural systems in the brain related to attentional control. Their flagship product, EndeavorRx, is the first and only FDA-approved prescription video game treatment for children aged 8-17 with primarily inattentive or combined-type ADHD. Building on this technology, Akili launched EndeavorOTC, an over-the-counter treatment for adults with ADHD available without prescription. Both products are built on the company's patented Selective Stimulus Management Engine (SSME) technology, which uses adaptive algorithms to personalize treatment difficulty for each individual patient. The technology has been rigorously evaluated across more than 30 clinical trials, including the STARS-ADHD study published in The Lancet Digital Health. Akili's approach represents a fundamental shift in how medicine is designed, delivered, and experienced—creating treatments that are not just effective, but engaging and enjoyable. The company continues to research applications of their technology across multiple cognitive conditions beyond ADHD, including autism spectrum disorder and sensory processing dysfunction.
Mission & Story
Mission
We believe effective medicine can also be fun and engaging. We're creating a new class of digital medicines for people living with cognitive impairments, delivered through captivating video game experiences.
Founding Story
Developed through the collaboration of world-renowned cognitive neuroscientists and acclaimed entertainment and technology designers to create an entirely new category of medicine built on extensive peer-reviewed research.
Clinical Focus
Medical conditions and clinical areas addressed by Akili.
Who It Serves
Milestones & Awards
Recent Milestones
Launch of EndeavorOTC for adults with ADHD (over-the-counter, available on App Store and Google Play); FDA authorization for EndeavorRx as first prescription video game treatment; CE Mark certification in Europe; Publication of STARS-ADHD trial in The Lancet Digital Health; 2023 ADHD in Workplace Report
Awards & Recognition
First FDA-approved prescription video game treatment; First-of-its-kind over-the-counter digital treatment for adult ADHD
Social & Media
Latest Updates
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 48 →
AbleTo
AI-powered mental health and digital therapeutics platform delivering behavioral health interventions and therapy support.
Alma
Alma is a mental health care platform that connects clients with therapists who accept insurance across all 50 states. The company supports both clients seeking affordable therapy and mental health providers with practice management tools and insurance credentialing.
Alto Neuroscience
Alto Neuroscience develops biology-driven precision medicines for neuropsychiatric conditions. The company uses brain biology measurements to predict clinical response and identify patients most likely to benefit from their drug candidates.
BeMe Health
BeMe is a mobile mental health platform designed specifically for teens and young adults. The app provides a safe space for mood tracking, personalized content, live 1:1 coaching, and crisis support to improve emotional well-being and mental health.
Big Health
Big Health provides FDA-cleared digital therapeutics delivering cognitive behavioral therapy (CBT) for insomnia and anxiety. Their prescription products, SleepioRx and DaylightRx, serve health systems, health plans, and employers with evidence-based mental health solutions backed by 100+ peer-reviewed publications.
Blueprint Health
Blueprint provides an AI-powered assistant for mental health therapists that automates clinical documentation, generates treatment plans, and delivers clinical support. The platform works alongside existing EHRs or as a standalone AI-native EHR with integrated scheduling, telehealth, billing, and insurance management.
Boulder Care
Boulder Care provides telehealth-based addiction treatment for substance use disorder (SUD), including opioid use disorder (OUD) and alcohol use disorder (AUD). The company delivers whole-person, coordinated outpatient care through a secure mobile app, including medication-assisted treatment (MAT) with Suboxone and other medications, supported by dedicated care teams.
Brightline
Brightline is an award-winning pediatric mental health practice providing expert therapy, psychological testing, and psychiatry services to children and teens up to age 18. The company offers both in-person care at clinics in New York and online services across NY, NJ, CT, MA, and WA.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.